FRAT1 Antikörper (AA 99-128)
Kurzübersicht für FRAT1 Antikörper (AA 99-128) (ABIN5534285)
Target
Alle FRAT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 99-128
-
Aufreinigung
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
-
Immunogen
- This FRAT1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 99-128 amino acids from the Central region of human FRAT1.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 2 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- FRAT1 (Frequently Rearranged in Advanced T-Cell Lymphomas (FRAT1))
-
Andere Bezeichnung
- FRAT1
-
Hintergrund
- FRAT1 belongs to the GSK-3-binding protein family. It may function in tumor progression and in lymphomagenesis. It positively regulates the Wnt signaling pathway by stabilizing beta-catenin through the association with GSK-3. It may play a role in tumor progression and collaborate with PIM1 and MYC in lymphomagenesis.
-
Molekulargewicht
- 29 kDa
-
Gen-ID
- 10023
-
UniProt
- Q92837
Target
-